Bioceltix S.A. (WSE:BCX)
Poland flag Poland · Delayed Price · Currency is PLN
100.00
-0.80 (-0.79%)
Oct 6, 2025, 12:28 PM CET

Bioceltix Ratios and Metrics

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21
496431372133172
Market Cap Growth
36.96%16.07%179.48%-22.49%-
Enterprise Value
466394357130-
Last Close Price
100.8087.6090.0038.8052.20
PB Ratio
15.8111.2335.5125.8228.60
P/TBV Ratio
15.8111.2335.5125.8228.60
Debt / Equity Ratio
-0.020.020.060.09
Inventory Turnover
-126.03---
Quick Ratio
101.0812.085.231.943.41
Current Ratio
101.0812.345.242.683.42
Return on Equity (ROE)
-36.70%-60.95%-175.28%-160.02%-
Return on Assets (ROA)
-20.29%-34.54%-85.92%-70.62%-
Return on Capital (ROIC)
-23.24%-37.80%-108.90%-93.47%-
Earnings Yield
-2.82%-3.45%-3.68%-6.71%-2.56%
FCF Yield
-2.85%-4.13%-4.09%-6.19%-2.35%
Buyback Yield / Dilution
-19.13%-15.76%-17.48%-5.54%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.